Floatz logo

60 assets in Acute Leukemia

Therapeutic assets addressing Acute Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Vic-1911
Acute Leukemia
Masonic Cancer Center, University of MinnesotaP1/2CC (42)
Itacitinib
Acute Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1CC (41)
3d189
Acute Leukemia
3D MedicinesP1C (39)
cd19/baff-r in vivo car-t cell intravenous infusion
Acute Leukemia
Qi dengP1C (39)
Gilteritinib
Acute Leukemia
Kura Oncology, Inc.P1C (39)
Liraglutide
Acute Leukemia
University of ChicagoEarly P1C (39)
Plerixafor
Acute Leukemia
Stanford UniversityP1C (39)
Quail-100
Acute Leukemia
Laguna Biotherapeutics, Inc.P1C (39)
Ziftomenib
Acute Leukemia
Kura Oncology, Inc.P1C (39)
Lbs-007
Acute Leukemia
Lin BioScience, IncP1/2NR ()
Showing 51 to 60 of 60 assets
PreviousPage 2 of 2Next